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Abstract
Background—Deaths and certain illnesses onboard ships arriving at US ports are required to be 
reported to the US Centers for Disease Control and Prevention (CDC), and notifications of certain 
illnesses are requested.
Methods—We performed a descriptive analysis of required maritime illness and death reports of 
presumptive diagnoses and requested notifications to CDC’s Division of Global Migration and 
Quarantine, which manages CDC’s Quarantine Stations, from January 2010 to December 2014.
Results—CDC Quarantine Stations received 2891 individual maritime case reports: 76.8% 
(2221/2891) illness reports, and 23.2% (670/2891) death reports. The most frequent individual 
illness reported was varicella (35.9%, 797/2221) and the most frequently reported causes of death 
were cardiovascular- or pulmonary-related conditions (79.6%, 533/670). There were 7695 cases of 
influenza-like illness received within aggregate notifications. CDC coordinated 63 contact 
investigations with partners to identify 972 contacts; 88.0% (855/972) were notified. There was 
documentation of 6.5% (19/293) receiving post-exposure prophylaxis. Three pertussis contacts 
were identified as secondary cases; and one tuberculosis contact was diagnosed with active 
tuberculosis.
Conclusion—These data provide a picture of US maritime illness and death reporting and 
response. Varicella reports are the most frequent individual disease reports received. Contact 
investigations identified few cases of disease transmission.
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1. Background
In 2014, 13.5 million passengers and 5.1 million crew members arrived at US seaports by 
cruise ship [unpublished data provided to the Centers for Disease Control and Prevention 
(CDC) by US Customs and Border Protection]. In addition, 35,000 passengers and 900,000 
crew members arrived at US seaports by cargo ships in 2014. Many of these travelers, 
particularly crew members, were from countries that may have lower vaccine coverage and 
less availability to healthcare than the United States. Although cruise ships have medical 
facilities onboard, laboratory diagnostic capacity is limited; recommended onboard tests 
include rapid antigen tests for malaria, influenza, and Legionnella [1].
Federal regulations require the master of a ship to immediately report to CDC any death or 
certain illnesses that occur within 15 days before entering or 15 days after leaving a US port 
[2]. Because a diagnosis cannot always be made aboard the ship, certain signs and symptoms 
are required to be reported. During the time frame of data collection for this analysis, 
reporting was required for the following signs and symptoms: fever lasting more than 48 h; 
fever of any duration plus rash, swelling of the lymph nodes, or jaundice; or diarrhea. CDC 
also requested notifications of fever plus any of the following: difficulty breathing or 
suspected/confirmed pneumonia, persistent or bloody cough, headache with neck stiffness, 
reduced level of consciousness, unexplained bleeding, or persistent vomiting. In addition to 
the regulatory requirement to report individual reports of deaths due to influenza-like illness 
(ILI) and ILI due to a potentially novel strain of influenza, CDC requests individual case 
reports for ILI when the patient requires hospitalization, and immediate aggregate 
notifications of outbreaks. Since 2010, CDC has requested that cruise ships send the total 
number of ILI cases among passengers and crew at the end of each voyage, even if the 
number of cases of ILI was zero. Aggregate ILI notification is not requested from cargo 
ships. Gastrointestinal illness cases on cruise ships are reported to the CDC Vessel 
Sanitation Program (VSP).
CDC Quarantine Stations, managed by the Division of Global Migration and Quarantine, 
receive reports and notifications of illness or death from ship personnel; the US Coast 
Guard; Customs and Border Protection; state, territorial and local health departments; and 
health care facilities ashore. When a report is received, quarantine public health officers 
assess the case, request follow-up information if needed, and may consult with quarantine 
medical officers to determine if additional action, such as a contact investigation, onboard 
response, or notification to the health department, is warranted. Since 2005, the illnesses and 
deaths reported to CDC Quarantine Stations and resulting actions taken are recorded in the 
Quarantine Activity Reporting System (QARS), a secure Web-based database.
Past publications on US maritime surveillance data have included all conveyance death 
reporting from 2005 to 2008 [3], an analysis of varicella on cruise ships [4], and case reports 
describing illness aboard a cruise ship [5–7]. International studies of maritime 
Stamatakis et al. Page 2
Travel Med Infect Dis. Author manuscript; available in PMC 2018 March 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
communicable disease surveillance have described respiratory and gastrointestinal illness 
among passengers and crew on cruise ships [8] and trends in infectious disease mortality on 
merchant ships [9]. This is the first published comprehensive description of US maritime 
illness and death reporting and the resulting contact investigations.
2. Methods
Investigators queried the QARS database for maritime illness and death reports from 
January 1, 2010, to December 31, 2014. A case was defined as any illness or death reported 
to CDC on a ship with a presumptive diagnosis captured in QARS. A presumptive diagnosis 
is the diagnosis of potential public health concern when the case is initially reported to CDC. 
A final diagnosis is documented for a case based on information provided by healthcare 
facilities, health departments, medical examiners, or laboratories, when available, and review 
by a quarantine medical officer. These presumptive and final diagnoses represent 
surveillance categorizations and are based on the information available to CDC. 
Cardiovascular and pulmonary diseases are captured as a single category when considered 
not to be associated with infection. Public health actions (by the ship, health department, or 
CDC staff) may be recommended based on the presumptive diagnoses for onboard illnesses 
and deaths; thus, presumptive diagnoses were used in the analysis. Differences between 
numbers of presumptive and final diagnoses were quantified.
Reports of gastrointestinal illness on cargo ships to CDC Quarantine Stations are included in 
this analysis; however, reports of gastrointestinal illness on cruise ships are not included and 
are published by VSP [10]. Gastrointestinal illness is defined as diarrhea within a 24 h 
period, 3 or more episodes of loose stools or an occurrence of loose stools that is above the 
normal for the person, or vomiting and one or more of the following additional symptoms: 
one or more episodes of loose stools in a 24-h period, abdominal cramps, headache, muscle 
aches, or fever (temperature of 100.4 °F [38 °C] or greater) [11].
Descriptive analysis was used to characterize all individual illness and death reports. The 
presumptive diagnosis for all maritime reports during this time period was described for 
illnesses and deaths in both passengers and crew. Aggregate ILI were analyzed separately 
from individual ILI reports because the multiple differences between the reporting 
mechanisms limited their comparability. For example, unlike individual reports, aggregate 
ILI notifications had limited demographic detail collected (only differentiating passengers 
and crew), were submitted voluntarily at the end of each voyage, and were requested from 
cruise ships only. ILI cases that were submitted as individual reports, were included in the 
analysis with the other individual reports. Because the signs and symptoms of influenza are 
not specific and most persons who have a respiratory illness are not tested for influenza, ILI 
has been defined for surveillance purposes as an illness with fever plus either cough or sore 
throat in the absence of another diagnosis [11].
For the purposes of this analysis, presumptive or final diagnoses of public health concern 
included tuberculosis, measles, rubella, mumps, pertussis, and meningitis/meningococcal 
disease. Contact investigation was defined as an investigation due to a presumptive or final 
diagnosis of public health concern, with documentation identifying contacts and attempts 
Stamatakis et al. Page 3
Travel Med Infect Dis. Author manuscript; available in PMC 2018 March 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
made to notify, evaluate, or provide post-exposure prophylaxis (PEP) to the contacts. 
Investigators reviewed all disease reports to ensure that CDC’s criteria for cases of public 
health concern, contacts, and contact investigations were met as defined in Table 1. Public 
health responses for varicella and ILI outbreaks were defined as enhanced data collection 
rather than contact investigations because of differences in response protocols and lack of 
individual contact level information collected by CDC Quarantine Stations, and details of 
these responses are not included in this analysis. Contact investigations for communicable 
diseases of public health concern are described, including details of the number of contacts 
and secondary cases. Analyses were performed using SAS 9.3. This investigation was 
determined to be non-research by CDC’s human subjects review process.
3. Results
3.1. Demographics
From 2010 through 2014, 2891 individual reports were received by CDC Quarantine 
Stations; there were 2221 (76.8%) illness cases and 670 (23.2%) death cases.
Of the 1142 illness and death cases with known gender, 1310 (73.5%) were male, and 472 
(26.5%) were female (Table 2). Of 1656 reports with documented age, the mean age was 
36.1 years (inter-quartile range [IQR] = 17) at illness and 65.8 years (IQR = 22) at death. 
Mean age at illness was similar on cruise ships (35.8 years, IQR = 16) and cargo ships (36.4 
years, IQR = 18), while mean age at death was higher on cruise ships (67.2 years, IQR = 
18.5) than cargo ships (49.0 years, IQR = 14). Illnesses were reported more often in crew 
members (68.3%, 1517/2,221, p value < 0.0001) and deaths were reported more often in 
passengers (89.0%, 596/670, p value < 0.0001).
Illnesses and deaths were most commonly reported during travel, as opposed to before the 
voyage began or after the voyage was complete, for both cruise ships (71.9%, 1858/2586) 
and cargo ships (74.8%, 184/246).
3.2. Diagnoses
Of the 2221 illness reports, the most frequent diagnoses reported to CDC Quarantine 
Stations (Table 3) were varicella (797/2,221, 35.9%), ILI (702, 31.6%), respiratory tract 
infections other than ILI (174, 7.8%), and tuberculosis (120, 5.4%). The most common 
illness case-reports from cruise ships were varicella (740, 37.6%), ILI (675, 34.3%), and 
respiratory tract infections other than ILI (168, 8.5%), while varicella (53, 26.4%), 
gastroenteritis (45, 22.4%), and tuberculosis (30, 14.9%) were most commonly reported in 
passengers and crew aboard cargo ships. Of the 702 individual ILI reports received, one 
hundred thirty-nine cases (19.8%) were characterized as novel/pandemic influenza; all were 
reported in 2010 and were classified as influenza A(H1N1)pdm. Cardiovascular/pulmonary-
related conditions (79.6%, 533/670) were the most frequently reported cause of death. The 
most commonly reported illness diagnoses that were more frequent in passengers than crew 
were ILI (40.9% vs. 27.3%, p-value < 0.0001), other respiratory tract infections (17.1% vs. 
3.6%, p-value < 0.0001), and Legionnaires’ disease (5.1% vs. 0.1%, p-value < 0.0001). The 
most commonly reported illness diagnoses that were more frequent in crew members than 
Stamatakis et al. Page 4
Travel Med Infect Dis. Author manuscript; available in PMC 2018 March 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
passengers were varicella (44.5% vs. 17.3%, p-value < 0.0001), tuberculosis (7.0% vs. 2.0%, 
p-value < 0.0001), and gastroenteritis (3.2% vs. 0.7%, p-value = 0.0004). Of cases with both 
a presumptive diagnosis and a final diagnosis not categorized as “other”, 262 (10.4%) 
received a different final diagnosis than the presumptive diagnosis.
3.3. Aggregate ILI reports
From 2010 through 2014, there were 7695 aggregate notifications of cases of ILI onboard 
cruise vessels arriving into the United States: 4782 (62.1%) were ill passengers.
3.4. Contact investigations
From 2010 through 2014, CDC Quarantine Stations coordinated 63 contact investigations 
for communicable diseases of public health concern aboard cruise and cargo vessels (Table 
4). The largest number of contact investigations recorded occurred in 2014 (36.5%, n = 23). 
The number of contact investigations prior to 2014 ranged from 6 (9.5%) in 2010 to 15 
(23.8%) in 2013. Most (55, 87.3%) contact investigations were conducted on cruise ships; 
contact investigations were conducted on 8 cargo ships (for one measles case and 7 
tuberculosis cases).
Of the 63 index cases, 45 were crew members (71.4%), 48 (76.2%) were male; the mean age 
was 34.7 years. Illnesses were reported to CDC Quarantine Stations during travel for 36 of 
the index cases (57.1%), and after travel was completed for 27 index cases (42.8%). Six 
infected travelers (one with pertussis, one with rubella, one with meningococcal disease, and 
3 with tuberculosis) also traveled by commercial airline while infectious, resulting in 
additional airline contact investigations. All index cases were subsequently confirmed 
positive for their respective presumptive diagnosis with the exception of one measles and 
one tuberculosis index case; both were confirmed negative after initiation of a contact 
investigation. A diagnostic confirmation was not obtained for one traveler with a 
presumptive diagnosis of meningococcal meningitis who was treated with antibiotics and 
later tested negative. Of the 972 contacts identified, assessment, interview, or outcome 
information was available for 855 (88%) contacts. Crew members accounted for 697 
(71.7%) of the contacts, and passengers accounted for 275 (28.3%). Included in this count 
are 18 contacts of the tuberculosis index case whose diagnosis was later ruled out and 2 
contacts of the index case who later tested negative for measles. During 5 meningococcal 
disease contact investigations, there was documentation of post-exposure prophylaxis (PEP) 
provided by the ship medical crew to 7 passenger contacts and 9 crew contacts. During one 
pertussis contact investigation, a health department administered antimicrobial prophylaxis 
to 3 passenger contacts of the index case; secondary transmission was not detected. 
Distribution of PEP as recommended by CDC staff was not documented for 5 contact 
investigations.
Three secondary cases of pertussis were identified in travelers following onboard exposure. 
The secondary cases were family members and shared a cabin with the index case. Forty 
three tuberculosis contact investigations identified 547 contacts. Documentation of 
evaluation results were available for 472 (86.3%) contacts, 66 were diagnosed with latent 
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tuberculosis infection and one with active disease. It is unclear if these 67 contacts were 
infected during exposure to the index case onboard or from prior exposures.
3.5. In-person responses
Although most contact investigations involved communications with ships’ medical staff by 
phone or e-mail, CDC Quarantine Stations conducted 8 in-person responses (on 5 cruise 
ships, 2 fishing vessels, and an oil tanker) for 39 illnesses and a single death report. In-
person response was initiated because of the presence of onboard transmission or a request 
for assistance by ship personnel. The reported presumptive diagnoses of these cases were ILI 
(1 response, 17 cases), gastroenteritis (3 responses, 18 cases), rubella (2 responses, 2 cases), 
mumps (1 response, 1 case), and varicella (1 response, 2 cases). For 6 on-board responses 
that resulted in contact investigations, 52 contacts were identified. When on board, CDC 
staff interviewed contacts, collected specimens to be taken ashore for testing, were present 
for a medical examination, measured temperatures, and provided recommendations to 
captains and physicians.
4. Discussion
The reports and notifications of illnesses and deaths and resulting contact investigations 
described in this manuscript provide insight into the public health issues that are reported to 
CDC Quarantine Stations and how they are managed. However, it is important to note that 
illnesses and deaths onboard cruise and cargo ships are underreported, based on specific 
reporting requirements and requests, and that the magnitude of disease experienced by 
passengers and crew at sea is largely unknown [12].
As recognized in the maritime literature, our findings confirm that varicella [4] and ILI [7] 
remain among the most frequently reported illnesses from maritime conveyance and 
underscores the importance of being up-to-date on routine vaccinations before travel.
Given the lack of laboratory capacity in remote clinical environments, such as ship 
infirmaries, much of the laboratory testing for diseases of public health concern must occur 
on land. This may delay testing of specimen for disease confirmation and creates a 
significant challenge in the initiation of contact investigations in a timely manner. 
Occasionally, contact investigations were initiated and actions taken before laboratory 
confirmation occurred. This analysis identified only two index cases, for which contact 
investigations were initiated, who subsequently tested negative for their presumptive 
diagnoses. In both cases the need for timely action was considered appropriate in the 
absence of test results. The frequency of contact investigations increased from 2010 to 2014, 
perhaps due to broader contact investigation criteria, stricter reporting standards, or greater 
awareness of reporting standards, emphasizing the importance of the need for timely action.
In addition to testing capabilities, delays in ships’ ability to obtain some forms of post 
exposure prophylaxis at sea is a challenge. Although antimicrobial prophylaxis for 
meningococcal disease and pertussis is typically readily available, large quantities of MMR 
vaccine or immune globulin, for example, are not typically available on board. After measles 
exposure, vaccine is an effective form of prophylaxis for approximately 72 h, or immune 
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globulin can be given within 6 days of exposure. This short timeline makes it clear that the 
challenges created by testing and PEP acquisition delays, make it unlikely that prophylaxis 
can be effectively distributed if a measles exposure occurs on board. This point further 
stresses the importance of both passengers and crew being fully immune to vaccine-
preventable diseases such as measles, prior to embarkation.
Considerations by cruise and cargo lines to implement policies regarding immunization for 
crew, and recommendations for passengers to ensure they are up-to-date on routine 
immunizations before travel, will likely reduce the burden of certain illness aboard maritime 
conveyance. In addition, prevention measures for respiratory and gastrointestinal infections 
such as pre-travel advice, hand hygiene, strict reporting and isolation requirements, food 
safety measures have been found to be effective in the mitigation of disease transmission on 
ships [8,10].
During contact investigations, lack of prior exposure information for tuberculosis contact 
diagnosed with tuberculosis disease or those with latent tuberculosis infection provides an 
unclear picture of tuberculosis transmission on maritime vessels. Many crew members are 
from countries with high burden of tuberculosis, and previous exposure or infection status 
cannot be assessed from the information collected in QARS. While information about 
transmission on maritime conveyances is limited, prolonged time spent working and living 
in close, crowded spaces to individuals with infectious tuberculosis likely contributes to 
onboard transmission of tuberculosis in crew [13].
Confirmed cases of secondary transmission for most diseases of public health concern were 
relatively few and might have been prevented by prompt isolation or by high vaccination 
rates in the passenger population. It is also possible that secondary cases may not have been 
reported to public health, particularly if onset occurred after disembarkation. Often, CDC 
staff recommended PEP be administered to contacts by the ship medical staff and health 
departments conducting monitoring; however, in some reports, PEP provision was not 
documented in QARS. It is possible that administration of PEP to maritime contacts was 
higher than indicated in this analysis, because it is not required that this activity be reported 
to CDC.
This analysis has several limitations. These data are taken from a passive reporting system 
and may not represent the true burden of maritime morbidity and mortality; however, much 
of the reporting is required under federal regulations and may be more complete than if this 
information were merely requested. Reporting requirements are syndromic and during this 
timeframe most syndromes were reported by request. Aggregate ILI notifications were 
implemented during the 2009 H1N1 pandemic and were designed to monitor trends, detect 
outbreaks, and decrease the burden of individual case reporting. The notifications were not 
intended to provide the same surveillance information gained from individual illness reports 
and are therefore not comparable to individual illness reports because of differing 
methodologies. Limited confirmatory diagnostics are a challenge on maritime conveyance 
and public health response is often dependent on the presumptive diagnosis; however we 
found only a 10% difference in presumptive and final diagnoses. Reporting on cargo ships is 
typically performed by nonmedical personnel and may result in misclassification, and under 
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reporting of illness. Case definitions for conducting contact investigations and defining 
contacts underwent minor changes throughout the reporting timeframe. To address this, 
reports of diseases of public health concern were reviewed and categorized based on 
standard definitions for the purpose of this investigation.
5. Conclusions
Findings from this analysis emphasize the importance of up to date pre-travel vaccination for 
passengers and crew, prevention measures such as hand-hygiene, reporting, isolation, and 
food safety measures, and understanding the limitations of medical interventions on ships so 
that preparations can be made accordingly. This analysis is the first complete analysis of US 
maritime illness and death reporting, response, and follow-up. It provides vital public health 
information about diseases of public health concern, deaths on ships, how these events are 
being reported, outcomes, and patterns. These data will be used to inform maritime public 
health protocols and guidance, resource allocation, and research and evaluation projects. In 
2017, CDC updated its regulatory reporting requirements and definitions of “ill person” 
[11]. By ensuring cases meet the revised ill person definition, more accurate public health 
surveillance information is anticipated, providing the opportunity to better document and 
respond to illnesses at sea.
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Table 1
Centers for Disease Control and Prevention criteria for initiating maritime contact investigations and contact 
definitions, by disease.
Criteria to initiate contact investigation Definition of a contact
Measles
Any probable or confirmed measles casea 
determined to be contagious during travel
• Direct face-to-face contact of an unvaccinated person with a case during 
the period of infectivity (4 days before to 4 days after onset of rash)
• Shared confined space in close proximity for a prolonged period, such as 
1 h, with infectious case
Rubella
Any probable or confirmed rubella casea determined 
to be contagious during travel
• Direct face-to-face contact of an unvaccinated person with a case during 
the period of infectivity (7 days before to 7 days after onset of rash)
• Shared confined space in close proximity for a prolonged period, such as 
1 h, with infectious case
Tuberculosis
Infectious tuberculosis confirmed by positive sputum 
nucleic acid amplification test or culture AND at 
least one of the following:
• Sputum smear positive or cavitary 
disease on chest X-ray
• Multidrug-resistant or Extensively 
drug-resistant-tuberculosis
Consider starting contact investigation 
if high suspicion for TB but not 
confirmed: sputum smear positive, no 
or negative nucleic Acid 
Amplification test, results of culture 
pending, cavitary disease seen by 
CXR, responding to medications
• Cargo ship crew member contact—all other crew members on board 
within the 3 months before onset of symptoms that ultimately led to the 
tuberculosis diagnosis
• Cruise ship crew member contact—cabinmates, dining mates, bathroom 
mates, workmates, intimate partners, and friends. If index patient was a 
passenger, includes crew members with whom index patient had repeated 
and prolonged contact (i.e., interacted with ill passenger daily, e.g., 
waiter, cabin crew, steward, day care provider) within the 3 months 
before onset of symptoms that ultimately led to the tuberculosis 
diagnosis
• Cruise ship passenger contact—cabinmates, dining mates, intimate 
partners, friends, others in traveling party. If index patient was a crew 
member, includes passengers with whom index patient had repeated and 
prolonged contact (i.e., interacted with ill crew member daily, e.g., in 
dining room, cabin, or day care) within the 3 months before onset of 
symptoms that ultimately led to a diagnosis
Pertussis
Any probable or confirmed pertussis casea 
determined to be contagious during travel
• Direct face-to-face contact of an unvaccinated person with a case who is 
symptomatic
• Shared confined space in close proximity for a prolonged period, such as 
1 h, with a symptomatic case
Mumps
Any probable or confirmed mumps casea determined 
to be contagious during travel
• Direct face-to-face contact with of an unvaccinated person with a case 
during the period of infectivity (two days before to 5 days after onset of 
parotitis)
• Shared confined space in close proximity for a prolonged period of time, 
such as 1 h, with infectious case
Meningococcal disease
Any suspected, probable or confirmed 
meningococcal casea determined to be contagious 
during travel
• Direct contact with oral secretions during period of infectivity (7 days 
prior to symptom onset until 24 h after initiation of effective 
antimicrobial therapy)
• Cabin mates
• Daycare contacts
aConfirmed and probable cases defined according to Council of State and Territorial Epidemiologists position statements [14].
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Table 2
Maritime illness and death cases reported to the Centers for Disease Control and Prevention, 2010–2014, 
characterized by gender, age, year, type of traveler and vessel.
Illness Cases (n = 2221) Death-Cases (n = 670)
n (%) n (%)
Gender
 Male 868 (39.1) 442 (66)
 Female 274 (12.3) 198 (29.6)
 Unknown 1079 (48.6) 30 (4.5)
Age
 < 10 61 (2.7) 4 (0.6)
 10–19 38 (1.7) 4 (0.6)
 20–29 302 (13.6) 14 (2.1)
 30–39 316 (14.2) 24 (3.6)
 40–49 137 (6.2) 56 (8.4)
 50–59 54 (2.4) 84 (12.5)
 60–69 54 (2.4) 148 (22.1)
 ≥70 74 (3.3) 286 (42.7)
 Unknown 1185 (53.4) 50 (7.5)
Year
 2010 535 (24.1) 131 (19.6)
 2011 439 (19.8) 143 (21.3)
 2012 302 (34.3) 132 (19.7)
 2013 499 (22.5) 113 (16.9)
 2014 446 (20.1) 151 (22.5)
Traveler Type
 Passenger 704 (31.7) 596 (89)
 Crew 1517 (68.3) 74 (11)
Vessel Type
 Cruise 1970 (88.7) 616 (92.0)
 Cargo 201 (9.1) 45 (6.7)
 Othera 39 (1.7) 8 (1.2)
 Unknown 11 (0.5) 1 (0.1)
aOther vessel types include: fishing vessels, US military/Coast Guard ships, private/pleasure vessels, and research vessels.
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Table 3
Presumptive diagnoses of maritime illnesses and deaths reported to the Centers for Disease Control and 
Prevention 2010–2014, characterized by type of traveler.
Illness diagnosesa Traveler type Total (n = 2221)
Passenger (n = 704) Crew (n = 1517)
n (%) n (%) n (%)
Varicella 122 (17.3) 675 (44.5) 797 (35.9)
Influenza-like illness 288 (40.9) 414 (27.3) 702 (31.6)
Upper/lower respiratory tract infection 120 (17.1) 54 (3.6) 174 (7.8)
Tuberculosis 14 (2) 106 (7) 120 (5.4)
Gastroenteritisb 5 (0.7) 48 (3.2) 53 (2.4)
Legionnaires’ Disease 36 (5.1) 2 (0.1) 38 (1.7)
Mumps 13 (1.9) 22 (1.5) 35 (1.6)
Malaria 1 (0.1) 24 (1.6) 25 (1.1)
Meningitis/meningococcal disease 16 (2.3) 9 (0.6) 25 (1.1)
Rash 13 (1.9) 11 (0.7) 24 (1.1)
Hepatitis A 3 (0.4) 19 (1.3) 22 (1)
Measles 11 (1.6) 10 (0.7) 21 (1)
Fever 5 (0.7) 12 (0.8) 17 (0.8)
Dengue 1 (0.1) 9 (0.6) 10 (0.5)
Rubella 6 (0.9) 4 (0.3) 10 (0.5)
Pertussis 9 (1.3) 0 (0) 9 (0.4)
Chikungunya 2 (0.3) 6 (0.4) 8 (0.4)
Typhoid fever 0 (0) 5 (0.3) 5 (0.2)
Rabies 0 (0) 1 (0.1) 1 (0.1)
SARS 0 (0) 1 (0.1) 1 (0.1)
Otherc 34 (4.8) 77 (5.1) 111 (5)
Unknown 5 (0.7) 8 (0.5) 13 (0.6)
Presumptive cause of death Traveler type Total (n=670)
Passenger (n=596) Crew (n=74)
n (%) n (%) n (%)
Cardiovascular/pulmonary related condition 494 (82.9) 39 (52.7) 533 (79.6)
Influenza-like illness 4 (0.7) 2 (2.7) 6 (0.9)
Meningitis/meningococcal disease 3(0.5) 2 (2.7) 5 (0.8)
Otherd 73 (12.3) 10 (13.5) 83 (12.4)
Unknown 16 (2.7) 20 (27) 36 (5.4)
Upper/lower respiratory tract infection 6 (1) 1 (1.4) 7 (1)
a
This table does not include aggregate influenza/ILI reports.
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bGastrointestinal illness cases on cruise ships are reported to the CDC Vessel Sanitation Program and are not included.
cOther illness reports include sexually transmitted infections/human immunodeficiency virus, suspected Ebola, vector-borne disease, allergy/
allergic reaction, miscarriage or abortion, trauma, seizure disorder, viral/bacterial/unspecified infection, acute abdomen, cancer, pancreatic 
infection, jaundice/hepatitis disorder, and encephalitis.
dOther death reports include: cancer, trauma/accident, suicide, stroke, drug overdose, natural causes, allergic reaction, hepatic disorder, 
gastrointestinal hemorrhage, and diabetes.
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